Keep an Eye Out for the Chance to Sell Biotech
XBI seems to be heading toward support and a bounce would be a good chance to do some selling.
Don’t Let the Poor Market Get You Down: I See Plenty of Good Charts
A classic Monday morning bull trap has snapped, and selling pressure is ramping up again.
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO
Leveraging wound care to tackle the much larger aesthetics market.
This Small-Cap Biotech Is Turning Heads on Wall Street
Here is how I’m playing a setup in a new name with upcoming catalysts.
While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
I’m Eyeing 2 Biopharma Stocks While Everyone Else Gawks at Big Tech
Here are a couple of oncology names that are steadily moving up.
A Low-Priced Biotech Is Back in the Bargain Bin – And I’m Adding
This beaten-down small-cap offers rich options premiums, and an attractive setup.
As China Summit Steals Headlines, I Am Eyeing These Three Stocks
This is how I’m trading 3 names as I navigate a choppy market amid U.S.-China meeting.